SINUVA™Sinus Implant For Nasal Polyps
We’ve all been congested at some point in our lives but when that congestion becomes chronic it can turn in to more than just an inconvenience. If your chronic congestion is caused by nasal polyps, SINUVA™ may be the answer you’ve been looking for. At ENTACC we will work closely with you to decide the best treatment for your congestion based on your personal situation while explaining every step throughout the process.
What is SINUVA™?
SINUVA™ is a nasal implant that slowly releases medication to shrink or eliminate your nasal polyps. Over time you will begin to be able to breathe through your nose again and once SINUVA™ is in place it can’t typically be felt.
How does SINUVA™ work and how is it put in place?
SINUVA™ (mometasone furoate) is put in place during a routine office visit. Your doctor will first numb up the area using a local or topical anesthesia and then place SINUVA™ in the sinus cavity through the nasal opening.
SINUVA™ works by opening up in the sinus cavity and then slowly releasing anit-inflammatory medication over the course of 90 days. As the medication is released your nasal polyps will reduce in size allowing you to breathe through your nose again.
The benefits of SINUVA™
At 90 days, or earlier in some cases, you should see the full range of benefits provided by SINUVA™ which include:
- A significant reduction in nasal polyp congestion and obstruction
- An improved sense of smell
There are some complications that were observed in the clinical trial that include bronchitis, upper respiratory infection, middle ear infection, headache, light-headedness, asthma, and nose bleed. SINUVA™ is indicated for adults with nasal polyps who have had ethmoid sinus surgery.
Click here for more info about SINUVA™
Get nasal polyp and congestion treatment at ENTACC
If you are suffering from chronic nasal congestion we will work with you to get the right diagnosis and offer the best treatment available.
SINUVA™ Sinus Implant is a drug-releasing (mometasone furoate) implant indicated for the treatment of nasal polyps, in patients ≥ 18 years of age who have had ethmoid sinus surgery.
.IMPORTANT SAFETY INFORMATION
If you have a known hypersensitivity to the mometasone furoate drug or any of the ingredients in SINUVA™, do not use SINUVA™. Hypersensitivity reactions, including rash, itch, and swelling have been reported with use of steroids. If steroid effects such as Cushing Syndrome and adrenal suppression appear, consult your healthcare professional.
SINUVA™ is made from bioabsorbable polymers designed to soften over time. As the implant softens and polyps decrease, the implant may be expelled out of the nose on its own or with actions such as sneezing or forceful nose blowing. The implant can be removed 90 days after placement or earlier at the physician’s discretion. Repeat administration of SINUVA™ has not been studied.
As with other endoscopic sinus procedures, there are risks associated with the insertion or removal of SINUVA. SINUVA™ should be inserted by physicians trained in otolaryngology. Discuss risks related to insertion or removal of SINUVA™ with your healthcare professional. Your healthcare professional will monitor the nasal tissue adjacent to the SINUVA™ Sinus Implant for any signs of bleeding, irritation, infection, or perforation. SINUVA™ should not be used in patients with nasal ulcers or trauma. The most common adverse reactions observed in clinical studies were bronchitis, upper respiratory or middle ear infection, headache, lightheadedness, asthma, and nose bleed.
If you experience excessive nasal bleeding, symptoms of infection or symptoms suggesting that the implant has moved, such as irritation or a choking sensation in the back of the throat, immediately contact a healthcare professional. Close monitoring is recommended if you have a change of vision or a history of increased intraocular pressure, glaucoma and/or cataracts.
You may report side effects to your physician or to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Intersect ENT at 1-866-531-6004. RX Only. For important risk and use information about SINUVA™, please see Full Prescribing Information or visit www.SINUVA.com.